Introduction
Specific processing of the human immunodeficiency virus type 1 (HIV-1) gag-pol polyprotein by the virusencoded protease yields the structural gag gene products p24CA, pl7MA and pl5NC, as well as non-structural proteins, reverse transcriptase, endonuclease and protease (reviewed in Cann & Karn, 1989; Wills & Craven, 1991) . The HIV-I protease originates from a large gagprt-pol polyprotein precursor, presumably as a result of intermolecular autoprocessing events Mous et al., 1988) . It belongs to the aspartyl protease family and its active site contains the consensus D-T-G sequence (reviewed in Krafisslich & Wimmer, 1988) . It is active as a dimer (Katoh et al., 1989; Miller et al., 1989b) and is inhibited in vitro by pepstatin (Seelmeier et al., 1988; Katoh et al., 1987) . Since specific proteolytic cleavages are essential for assembly of infectious HIV virions (Kohl et al., 1988; Peng et al., 1989; Gelderblom, 1991) , the protease represents one of the possible targets for enzyme-directed anti-AIDS therapy (reviewed in Skalka, 1989; Tomasselli et al., 1991) . HIV-1 protease has been produced in bacteria (Debouck et al., 1987; Graves et al., 1988) , chemically synthesized (Schneider & Kent, 1988) , crystallized (Miller et al., 1989a Navia et al., 1989) and cocrystallized with peptide-based specific inhibitors (Erickson et al., 1990; Miller et al., 1989b; .
The aim of the present study was to analyse the mechanism of autocatalytic processing of HIV-1 protease at its N and C termini, and its subsequent release from a fusion protein. For this purpose, as an alternative to in vitro chemical or in vivo biological synthesis, the HIV protease was expressed from a synthetic gene cloned into a bacterial expression vector. We cloned the prt gene in Escherichia coli, unfused or fused in phase to the 5' or 3' end of the bacterial lacZ gene (upstream or downstream position, respectively). Our approach has several advantages compared to previously described production systems. (i) A synthetic gene sequence has more versatility for further genetic manipulations; (ii) the protease gene sequence was designed for optimal codon usage in E. coli; (iii) since the cloned protease was expected to be toxic for the recipient cell (Hostomsky et al., 1989) , the protease gene was cloned under the strong but tightly regulated araB promoter (Cagnon et al., 1991) ; (iv) the yield of the fl-galactosidase (fl-gal)-fused gene products could be monitored easily using a simple flgal enzymic assay; (v) purification of HIV-1 protease 0001-0519 © 1992 SGM
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might be achieved by affinity chromatography of protease-fl-gal fusion on immobilized fl-gal substrate or anti-fl-gal antibody. Bacterial fl-gal has also been recently used to monitor the HIV protease activity upon insertion of one of its specific sites into the lacZ gene (Baum et al., 1990) .
The HIV-1 protease sequence is flanked by two processing sites, SFNF*PQIT at its N terminus and TLNF*PISPI at its C terminus. Cleavage of the protease precursor and release from the protease-fl-gal fusion protein was analysed by mutagenesis of amino acids downstream of the F-P scissile bond, at positions P4' and P5' in the C-terminal processing site and at position P3' in a consensus N-terminal site placed at the protease-flgal junction. The tolerance to amino acid residue substitutions was thus evaluated from the rate of protease-fl-gal cleavage. We found that mutations at subsites P4' and P5' had no apparent effect on cleavage, but that the P3' position in the N-terminal site showed some sensitivity to amino acid substitutions with strong effects on secondary structure.
Methods
Bacterial strains and plasmids. E. coli strain TG-I (Amersham) was used for cloning, and MC1061 (Casadaban & Cohen, 1980) for gene expression. Cells were grown in LB medium supplemented with ampicillin (100 ~tg/ml; LBamp). The unfused protease gene was constructed from oligonucleotide blocks directly assembled into pCrisl0, a derivative of pKK233-2 (Amman & Brosius, 1985) which differs from pKK233-2 by its synthetic cloning cassette (V. Valverde et al., unpublished results), fl-gal-protease fusion constructs were directly assembled into pARA14. Plasmid pARA14 contains an arabinoseinducible promoter, termed arab (Cagnon et al., 1991) , and constituted our expression vector. For induction of gene expression, overnight cultures were diluted 20-fold in LBamp, and incubated at 37 °C until they reached an optical density at 600 nm (OD6oo) of 0-5. Arabinose was then added to the cultures to a final concentration of 0.2%.
Nomenclature. PR100 and PRI07 refer to the mature protease and protease precursor of 100 and 107 amino acid residues, respectively, including the initiator codon, methionine. When the prt gene was fused to the 5' end of the lacZ gene (upstream position), the resulting in-phase fusion protein was called PR107-fl-gal or PR100-fl-gal. When prt was fused to the 3' end of lacZ (downstream position) the name was fl-gal-PR107. No fl-gal-PR100 fusion protein was constructed since this protein would have lacked the protease N-terminal processing site at the fl-gal-protease junction. The protease mutant named G33 had a glycine replacing the aspartyl residue 33 in the PR107 precursor, which corresponded to D (25) in the active site of the mature protease. The corresponding upstream fusion product was termed G33-fl-gal. RR-flgal designates a B-gal-fused protease variant in which the basic dipeptide Arg-Arg at positions P4' and P5' from the scissile bond at the PR107 fl-gal junction was substituted for the neutral Pro-Gly dipeptide. When a sequence homologous to the protease N-terminal processing site, but containing a suppressible amber stop codon in lieu of the isoleucine codon at position P3', was introduced at the downstream PR107 fl-gal junction, the resulting plasmid was referred to as PRambYLZ. Amber suppressions at position P3' in this junction sequence gave rise to PY mutants. A schematic drawing of our different gene constructs is presented in Fig. I (a) .
Gene constructions. Oligonucleotides were synthesized on an Applied BioSystems 380A DNA synthesizer (Applied BioSystems) and purified as trityl derivatives on Nensorb Prep columns (NEN Research products) according to the manufacturer's specifications. They were enzymically phosphorylated as previously described (Normanly et al., 1986) . Two different HIV-1 prt genes were constructed. The first one encoded the mature form of protease of 100 amino acid residues, starting its sequence with the Met (1)-Pro (2) dipeptide whereas the second encoded a precursor form of 107 amino acids. The PR107 gene contained an additional 5' nucleotide sequence encoding the heptapeptide (M)GTVSFNF (not counting the initiator methionine) present within the gag-prt-pol polyprotein, at the gag-protease junction, thus reconstituting the original Phe-Pro dipeptide of the N-terminal protease processing site (Darke et al., 1988 (Darke et al., , 1989 .
Both genes for the unfused protease constructs PR100 and PR107 were assembled stepwise from 20 complementary synthetic oligonucleotides annealed and ligated into three adapting building blocks (Fig.  1 b) . Oligonucleotides corresponding to the protease coding strand were given odd numbers, and the even numbers corresponded to the noncoding strand (Fig. lc) .
Step 1, oligonucleotides C1 to C8 were annealed and cloned between the HindlII and BgllI restriction sites of pCrisl0.
Step 2, the central part of the gene (oligonucleotides M1 to M6) was inserted between the BgllI and NarI sites.
Step 3, the 5' end of the PR100-encoding gene was reconstituted from oligonucleotide pairs N1-N2, N5-N6 and N7-N8, cloned between NarI and NcoI; for the 5' end of PR107, N3-N4 was inserted in lieu of N l-N2 (Fig. 1 c, and inset e). For optimal expression, the sequence was designed according to the codon usage of E. coli (Fig. 1 c) . All gene constructs were verified by DNA sequencing (Sanger et al., 1977) . PR100 and PR107 genes were then inserted into the pARA14 expression vector, under the control of the arabinose-inducible promoter arab (Cagnon et al., 1991) .
In-phase fl-gal fusions were directly constructed into the pARA14 expression vector already containing the gene for PR100 or PR107. The downstream fusion fl-gal-PR 107 was obtained by insertion of the plZ4 Ncol fl-gal gene cassette (V. Valverde et al., unpublished) into the NcoI site of PRI07. The two upstream fusions PRl00-fl-gal and PR107-flgal were generated by ligating the 5' end of the lacZgene to the 3' end of the PR100 or PRI07 gene. This was achieved by first cloning the L1 linker sequence (Fig. I d) at the 3' end of the prt gene. The plZ2 cassette (V. Valverde et al., unpublished) was then inserted between the SalI and Hindlll sites, within the L1 and ARAI4 sequences, respectively. The L1 linker was then mutated into the L0 linker ( Fig. 1 d) , to obtain the PRl00-fl-gal and PRl07-fl-gal fusions.
Site-directed mutagenesis at the catalytic site and protease-fl-gal junction. The phosphorothioate method (Taylor et al., 1985) was used to introduce two substitutions into the active site of the protease, G and T substituting for A and C at nucleotides 100 and 101 of the PR107 gene, respectively (Fig. 1 d) . This created a new KpnI site and changed the D (33) residue of the D-T-G triad (position 25 in the mature enzyme) into a glycine. This gave rise to the unfused G33 and fl-gal-fused G33-fl-gal mutant constructs (Fig. 1 a) .
The protease-fl-gal junction in PR100-fl-gal and PR107 fl-gal fusions consisted of the sequence TLNF*PISP, representing the Cterminal processing site of the protease. By our cloning strategy (see above), the RR-fl-gal fusion was obtained first, since it contained the L1 linker encoding the junction sequence LNF*PISRRGI. Using the same method (Taylor et al., 1985) , the L1 linker was then mutated into the L0 sequence (Fig. ld) , encoding the sequence LNF*PISPGGI. This latter sequence better mimicked the natural C-terminal processing site LNF*PISPIGI, in terms of side chain electric charges and overall conformation. sequence LNF*PISPGGI, consensus to the C-terminal processing site; L1 for the mutant sequence LNF*PISRRGI, in which the proline-isoleucine dipeptide at the P4' and P5" subsites was replaced by Arg-Arg. In the inset (e) are shown the two complementary oligonucleotides used to construct the gene for PR100 protease, N1 and N2 replacing N3 and N4 at the 5', end.
Amber mutation suppressor tRNA scanning. A double-stranded oligonucleotide sequence (coding strand: 5' TGCACTCT-GAACTTCCCTCAGTAGACTGGGGATCCA 3') encoding the consensus N-terminal processing site TLNF*PQITL was synthesized, with an amber codon replacing the isoleucine codon at position P3' of the scissile bond. The TLNF*PQambTL-encoding nucleotide sequence was then inserted at the PR107-fl-gal junction, between the ApaLI site at the 3' end of the precursor protease gene and the HindllI site in the pARA plasmid. The PR107 gene with the stop codon-containing junction sequence was then fused to the 5' end of the lacZ gene, giving rise to the PRamb3"LZ plasmid. A set of 12 amber tRNA suppressor genes cloned in pct2 vector (Kleina et al., 1990a, b; Normanly et al., 1986, i990) were tested for co-expression with PRamb3'LZ in the MC1061 strain. The fl-gal assay was used to estimate the efficiency of the amber suppression, as compared to the control PR107-#-gal fusion which contained a non-mutated C-terminal cleavage site as its junction sequence. Extracts from cells expressing
PRamb3'LZ only were assayed for the #-gal assay and showed that there was no detectable reinitiation of protein synthesis on the lacZ mRNA downstream of the amber codon. The extent of protease autoprocessing in the presence of suppressor tRNAs was estimated by the protein ratio in the 127K and 116K bands ( Fig. 3) , representing the protease-fl-gal fusion protein and fl-gal released from the protease, respectively. The 127K/l16K doublets were scanned on anti-fl-gal immunoblot patterns of SDS-polyacrylamide gels.
Enzyme assays, fl-Gal activity was assayed in extracts from toluenepermeabilized cells by hydrolysis of o-nitrophenyl-fl-o-galactoside (ONPG) (Miller, 1972) . For protease assay, 1 ml aliquots of arabinoseinduced cell culture taken at different time intervals were pelleted, washed in TN buffer (20 mM-Tris-HCl pH 7-5, 0-1 M-NaCI) and lysed in 50 ~tl of lysis buffer at 4 °C overnight with gentle mixing. Lysis buffer was made of 50 mM-Tri~HCI pH 7.5, 1 mM-DTT, 0.01% lysozyme, 0.1~ NP40, 1 mg/ml DNase I and a cocktail of protease inhibitors (Darke et al., 1988) . The precursor to p24CA0'~ produced in a baculovirus expression system (Royer et al., 1991) was used as the substrate for protease. Aliquots (10 ~tl) of gag polyprotein (0.5 to 1.0 ~tg) in 0.2 M-sodium phosphate buffer pH 6,5, 1 M-NaC1, 5% glycerol and 0.25~ NP40 were incubated with 10 ~tl of bacterial cell lysate at 27 °C and the reaction was stopped at different time intervals by addition of 20 ~tl of SDS-PAGE sample buffer. The gag precursor cleavage products were analyzed by SDS PAGE and immunoblotting with gagspecific antibody.
Biochemical and immunological analyses. Bacterial proteins were analysed by SDS PAGE (15~) in a discontinuous buffer system (Laemmli, 1970) . In a typical experiment, 1 ml bacterial cell culture was pelleted, washed with TN buffer, resuspended in 100 ~tl of TN buffer, mixed with 100 ~tl of SDS-urea-2-mercaptoethanol sample buffer and denatured at 100°C for 2min. Gels were stained or electrically transferred to nitrocellulose membrane (BA85, Schleicher & Sch~ll) for 45 min at 180 mA in a semi-dry apparatus (Millipore SDE). Membranes were reacted with anti-fl-gal (Research Plus) or anti-HIV-I protease rabbit polyclonal antibody (a gift from Dr E. Cheng, DuPont) and a phosphatase-labelled anti-rabbit IgG conjugate (sigma). Gag polyprotein products were detected on blots by reaction with an anti-pr55-p24CA0~ mouse monoclonal antibody (Epiclone-5001; Epitope Inc.) and a phosphatase-labelled anti-mouse IgG conjugate (Sigma). ELISA was performed using commercially available bacterial fl-gal (Sigma) and anti-fl-gal antibody (Research Plus).
For protein microsequencing, proteins were partially purified by acetone fractionation from bacterial cell lysates (Hansen et al., 1988 ). The acetone precipitate was then chromatographed on FPLC-MonoS column in 50mM-sodium 2-(N-morpholino)ethanesulphonic acid buffer pH 6.5, 1 mM-disodium EDTA, 10~ glycerol (Pharmacia). Protease was eluted at 0.2 M-NaCI and its purification was achieved by preparative SDS-PAGE in a Tricine-buffered system (Sch/igger &von Jagow, 1987). For fl-gal and protease, the 116K and 11K bands were transferred to Immobilon membranes (Ploug et al., 1989) and aminoterminal sequences were determined using an Applied BioSystems 470A protein sequencer coupled to an Applied BioSystems 120A PTH Analyser.
Electron and immunoelectron microscopy. E. coil cells fixed in 2-5~ glutaraldehyde in 0.1 M-phosphate buffer pH 7.5, for 1 h at 4 °C, were post-fixed with 2~ osmium tetroxide in water and embedded in Epon (Epox-812; Fullam). Immunogold staining (IGS) was carried out by successive reactions of cell sections with primary anti-/~-gal or antiprotease rabbit antibody overnight at 4 °C (at a dilution of 10 ~tg/ml in Tris-buffered saline), and 5 nm colloidal gold-labelled anti-rabbit IgG antibody for 1 h at room temperature (single IGS reaction). For double IGS, specimens were first simultaneously incubated with mouse monoclonal anti-fl-gal antibody (Sigma) and rabbit polyclonal antiprotease antibody, then with 1 nm gold-labelled anti-rabbit IgG antibody and 5 nm gold-labelled anti-mouse IgG antibody (EM-GAM1 and EM-GAM5; BioCell Research Lab). Specimens were post-stained with 0.5~ uranyl acetate and examined under the Philips EM-300 electron microscope.
Results

Expression of fl-gal-fused and unfused HIV-1 protease and protease precursor in
The level of expression of protease and fl-gal synthesized in bacterial cells under the control of the araB promoter was estimated by SDS-PAGE and immunoblotting, and quantified by the fl-gal assay. In E. coli expressing the unfused construct PR107, a band at 11K reacting with anti-protease antibody appeared after 1 h of arabinose induction (Fig. 2, lane 6 ) and progressively increased with the time of induction (Fig. 2, lanes 7 and 8) . A similar pattern was obtained with the G33 mutant (Fig.  2, lanes 9 to 12) , whereas no specific IlK band was detected in the PR100 pattern (Fig. 2, lanes 1 to 4) . With the fused construct PR107-fl-gal, the anti-protease serum revealed a discrete band of 127K fusion protein as early as after 0.5 to 1 h of induction (Fig. 3a , lanes 5 and 6) and an intense band at IlK became visible after 2 h (Fig. 3a, lanes 7 and 8) . Several other discrete bands of intermediate cleavage products, ranging from 80K to 20K in apparent Mr were also seen on the blot (Fig. 3a , lanes 5 to 8). With the fl-gal-fused mutant G33-fl-gal, the 127K fusion band increased in intensity during the induction period, without detectable release of the 11K protease (Fig. 3a, lanes 13 to 16) . In contrast to PR107, PR107-fl-gal, G33 and G33-fl-gal, a low level of expression of protease and fused fl-gal-protease was obtained with PR100 and PR100-fl-gal (Fig. 2, lanes 1 to  4; Fig. 4a, lanes 9 to 12) , as well as with the downstream construct fl-gal-PR107 (Fig. 3a, lanes 9 to 12) . Immunoblotting with anti-fl-gal antibody (Fig. 3b) confirmed the results obtained with the anti-protease serum (Fig.  3a) . fl-Gal was expressed at much higher levels with PR107-fl-gal, G33-fl-gal and RR-fl-gal than with the other fusions fl-gal-PR107 and PR100-fl-gal ( Fig. 3b and  4b) .
The results of immunoblots were confirmed by fl-gal assays performed on cell extracts: the level of fl-gal expression with upstream fusions PR107-fl-gal, G33-flgal and RR-fl-gal was ninefold higher than with the downstream fusion fl-gal-PR107, and 15-fold higher than with PR100-fl-gal (Table 1 ). The common feature between all the highly expressed genes was the presence of the additional 5' sequence encoding the N-terminal precursor protease heptapeptide. To determine whether this enhanced expression of the cloned genes occurred at the transcriptional or post-transcriptional level, the overall quantity of protease mRNA expressed upon arabinose induction by the different fusion constructs was estimated by slot-blot hybridization, using 32p_ kinase-labelled oligonucleotide M6 as the ssDNA probe (Fig. 1 c) Ceils expressing PR100 (lanes 1 to 4), PR107 (5 to 8) and G33 mutant (9 to 12) were harvested after 0.5, 1, 2 and 4 h of arabinose induction, respectively. Lane M, prestained marker lane (18K and 14K markers are shown). Blot was reacted with anti-HIV-1 protease rabbit serum and phosphatase-labelled secondary antibody. (Miller, 1972) . Each value represents the average of five individual results obtained in triplicate experiments (S.E.M., 5 to 10% of the activity values). The fl-gal-specific activity was 1 x 105 U/mg, as estimated from stained gel scannings and ELISA. The value of 4444 to 4850 U/ml thus corresponded to 44 to 48 mg/1. t Ratio of protease-fused fl-gal to pARAI-lacZ value.
Ratio of protease-fused fl-gal to PR100-fl-gal value.
amount of protease m R N A expressed by the various constructs (data not shown), suggesting that the enhancing effect occurred at the post-transcriptional level.
The yield of HIV-1 protease obtained with the vector expressing the fusion construct PR107-fl-gal was estimated by three indirect methods, all of them based on flgal determination: (i) fl-gal enzymic assays (Miller, 1972) , from calculated specific activity of 105 units per mg of fl-gal protein; (ii) ELISA, using commercial fl-gal as the standard and anti-fl-gal serum; (iii) Coomassie blue staining of the 127K/116K doublet band of proteasefused and released fl-gal in S D S -P A G E , after calibrating the gel with purified fl-gal. The protease (I 1 K) represents about one-tenth of the mass of the fusion protein, in terms of polypeptide mass ratio (116K for fl-gal). Thirty to 50 mg of PR 107-fl-gal fusion protein was obtained per litre of cell culture after 4 h of arabinose induction. Assuming a 100~ efficiency for protease self-processing and release from the fusion protein, its theoretical recovery would be 3 to 5 mg of protease per litre, i.e. 1.2 to 2-0 mg per g of E. coli wet weight. A similar protease recovery (1 mg/l) was obtained from E. coli expressing a maltose-binding protein fusion construct (Louis et al., 1991) .
Activity, cytotoxicity and cellular distribution of fl-galfused and unfused protease and protease precursor in
The results of the immunoblot analysis, showing evidence of HIV-1 protease release from the wild-type fl-gal fusion constructs and accumulation of non-cleaved fusion protein with the G33-fl-gal mutant ( Fig. 3 and 4) , suggested that the cloned protease was enzymically active and capable of self-processing in vivo. It could therefore be anticipated that protease synthesized in E. coli upon arabinose induction would also be active on its natural gag substrate. To verify its specificity of cleavage in vitro, our protease was incubated with baculovirusexpressed 41K gag polyprotein as a substrate (pr41gag). Pr41 ~ag comprised the p l 7 M A and p25CA domains (amino acids 1 to 375 of the gag sequence), with only two unique protease sites , Tyr-Pro at the p17-p24 junction (amino acids 132 and 133), and LeuAla at the p24-p25 junction (positions 363 and 364), the Met-Met site at 377 and 378 being eliminated by carboxy truncation (Royer et al., 1991) .
As expected, the active site mutants G33 and G33-flgal showed no detectable proteolysis of pr41 gag (not shown), whereas all the other protease clones were found to cleave the gag polyprotein substrate at its two specific sites, yielding the characteristic anti-gag antibodyreacting p24-p25 doublet (Fig. 5) . The highest activity was obtained with PR107 and PR107-fl-gal, which converted almost all the gag precursor into p24-p25CA g°~ after 30 min of incubation (Fig. 5, lanes 3 and 7) . The lower proteolytic activity shown by the extracts of cells expressing PR100-fl-gal and fl-gal-PR 107 (Fig. 5 , lanes 9 to 12 and 13 to 16) reflected the lower levels of protease production from these two constructs (Fig. 2 to 4) . However, the difference in fused and unfused protease expression observed between some of our clones could be due to cytotoxicity of the protease and a negative feedback effect on protein synthesis. In addition, c.p.e. has been frequently found to be related to the cellular distribution of cloned foreign proteins. Arabinoseinduced cells were therefore analysed with respect to their growth rate, and the cellular localization of unfused and fl-gal-fused protease was examined by immunoelectron microscopy. As shown in Fig. 6 , no detectable cytotoxicity was observed with the fusion constructs, and expression of only unfused PR107 and G33 proteases resulted in a slight reduction of the growth rate after 4 h of induction. The similar patterns shown by the clones expressing the active PR107 protease and the inactive G33 mutant suggested that the observed c.p.e, was due to the cellular accumulation of a foreign protein rather than to proteolytic activity of the protease p e r se.
When lysates from cells expressing unfused protease or fl-gal alone were fractionated, most of the fl-gal and protease activities were recovered in the soluble supernatant (not shown). No inclusion body was observed under the electron microscope, and IGS showed that the cloned proteins (protease or /3-gal) were evenly distributed within the E. coli cytoplasm (not shown). In contrast, amorphous inclusions were found in cells expressing the two fused constructs PR107-fl-gal and G33-/~-gal. These intracellular inclusions reacted with both anti-/3-gal and anti-protease antibodies in single IGS reactions (Fig. 7a,  b) . In the PR107-/3-gal-expressing clone, the gold grain pattern was found to be different with anti-/~-gal and anti-protease antibodies:/~-gal molecules were observed inside and outside the inclusions, whereas protease was exclusively localized within the inclusion bodies (compare Fig. 7a and b) . Double IGS, using 1 and 5 nm colloidal gold particles specific for rabbit (anti-protease) and mouse (anti-fl-gal) antibodies, respectively, confirmed that the inclusions contained both fl-gal and protease molecules (Fig. 7 c) , and suggested that protease remained associated with the inclusion and in the vicinity of fl-gal molecules after proteolytic processing.
A utoprocessing of HIV-1 protease: proteolytic cleavage at the protease-fl-gal junction
For PR 107-fl-gal, as well as PR 100-fl-gal, cleavage at the F-P bond situated in the natural C-terminal site TLNF*PISP placed at the protease-fl-gal junction was required to yield the mature protease (Fig. l a) . As already shown in Fig. 3 (a) , the first band to appear at 0-5 h of induction in the PR107-fl-gal pattern was a 127K fusion protein detected with anti-protease antibody. A protease band at IlK occurred in significant amounts after 2 h of induction, concurrently with a doublet at 127K and 116K (Fig. 3b) . The 116K species was detected only with anti-fl-gal antibody (Fig. 3b) . No IlK band was visible in the G33-fl-gal mutant although large quantities of fusion protein accumulated at 127K (Fig.  3a, b, lanes 15 and 16) . All these data suggested that the protease was released from the fl-gal fusion protein by a mechanism of specific self-processing at the C-terminal site of the protease and not by proteolysis due to bacterial proteases. Although produced in much lower yields, the 127K fusion band of PRl00-fl-gal was cleaved at the same time of induction as that of PR107-fl-gal (Fig. 4) , with the occurrence of detectable protease activity in the cell lysates (Fig. 5, lanes 11 and 12) . This result suggested that, in the protease-fl-gal fusion construct, cleavage at the C-terminal F-P bond of protease was not significantly influenced by the presence of cleaved or uncleaved N-terminal precursor sequence.
Specificity of cleavage at the N-terminal SFNF*PQITL and C-terminal TLNF*PISP natural sites of the protease precursor
Compared to mature protease PRI00, PR107 precursor contained the additional N-terminal heptapeptide GTVSFNF present in thepol reading frame (Fig. 1 a) . To determine the specificity of cleavage at the N-terminal end of the protease precursor PR107 and at both the N and C termini of the fl-gal-fused protease precursor PR107-fl-gal expressed in E. coli, the 11K band produced by the PRI07 clone and the 11K and 116K bands from the PR107-fl-gal fusion construct were isolated and sequenced. The first six cycles showed the expected sequence P-Q-I-T-L-W for the two 11K proteases and P-I-S-P-G-G for the 116K processed fl-gal. This confirmed that protease could mature from its PR107 precursor, by cleavage at the N-terminal site and the protease-fl-gal junction, both cleavages occurring at specific F-P bonds.
Phenotype of mutants in the N-and C-terminal autoprocessing sites
Since any mutation upstream of the F-P scissile bond at the protease-fl-gal junction or downstream of the F-P bond in the N-terminal site would alter the protease sequence and could therefore affect its enzymic activity, we restricted our mutational analysis to residues downstream of the C-terminal automaturation site. The PI' and P2' positions have been extensively studied (Margolin et al., 1990; Partin et al., 1990; Tritch et al., 1991) , whereas the requirements for the P3', P4' and P5' subsites have not yet been clearly defined. The pattern of protease release by the RR-fl-gal mutant, as shown in Fig. 4(b) , was similar to its wild-type PR107-fl-gal equivalent (Fig. 3 b) , although a slightly delayed processing (0.5 to 1 h) could be observed. This suggested that the presence of the two positively charged arginine residues at subsites P4' and PS' in the C-terminal processing site did not significantly impair the F-P scissile bond cleavage.
To analyse the influence of the amino acid residue at position P3' in the N-terminal site on protease autoprocessing, the sequence TLNF*PQITL, consensus to the natural sequence SFNF* PQITL found at the N terminus of the protease, was introduced at the PR107-fl-gal junction. We constructed an appropriate vector, termed PRamb3"LZ, which expressed a fl-gal-fused protease in which the protease sequence was flanked by two consensus N-terminal processing sites, i.e. its natural upstream SFNF*PQITL site and a downstream site with an amber stop codon in place of the isoleucine codon (TLNF*PQambTL; Fig. ! a) . Any substitution at the P3' subsite, downstream of the F-P bond, would therefore not affect the protease sequence. The E. coli strain harbouring PRamb3'LZ was then transformed by each of 12 plasmids expresssing an amber suppressor tRNA, and protease autoprocessing at the protease-fl-gal junction was assayed by the occurrence of the 116K fl-gal band released from the 127K protease-fl-gal fusion in SDS-PAGE and immunoblotting.
As shown in Table 2 , the efficacy of suppression, determined from the fl-gal activity, was found to vary from 0.2~ (lysine) to 41~ (glycine) for the different suppressor tRNAs, a result which confirmed previous studies (Kleina et al., 1990b) . Protease autoprocessing was therefore analysed at late times of arabinose induction (4 h), to compensate for the low level of fl-gal expression obtained with certain suppressors. Due to amino acid mischarging by certain suppressor tRNAs (Normanly et al., 1990) , some amino acid substitutions (Normanly et al., t990) .
t The degree of amber suppression was estimated by fl-gal activity, expressed as units per ml (U/ml; Miller, 1972) . Controls were PR107-fl-gal (100% control for fl-gal activity and autoprocessing) and PRamb3"LZ alone (negative control for fl-gal and suppression activity).
:~ Protease autoprocessing was estimated by scanning of the 127K/116K doublet bands of protease-fused and protease-released fl-gal in immunoblots of SDS-polyacrylamide gels.
were under-represented (Table 2) . Only three amino acids substituting for isoleucine at position P3' were found to have some discrete deleterious effect on the protease autoprocessing efficiency. Glycine, histidine (94% H inserted) and proline (85~ P inserted) showed a slight but significant delay in protease processing. Gly2 tRNA inserted glycine and glutamic acid with similar efficiency, but comparison with GluA tRNA, which mainly inserted glutamic acid, allowed us to assign the observed effect on processing to the glycine substitution.
Discussion
In the present study we analysed HIV-1 protease autoprocessing using synthetic genes encoding a protease precursor of 107 amino acids (PR107) and the mature form of the enzyme (PR100), unfused and fused to the N terminus of fl-gal (PR107-fl-gal and PR100-fl-gal), or to its C terminus (fl-gal-PR107). It has to be kept in mind that the concept of 'autoprocessing' used for retroviral proteases has been based on the experimental observation that wild-type protease is released from proteasecontaining polyproteins expressed in E. coli, whereas the mutant protease domain is not (Debouck et al., 1987 (Debouck et al., , 1990 Kraiisslich & Wimmer, 1988; Loeb et al., 1989; Mouset al., 1988; Strickler et al., 1989 ; and refer to Fig. 3) . However, such results do not unambiguously prove that the PR domain embedded in a fusion construct is itself an active protease. It cannot be excluded that a low level of cellular proteolytic activity might randomly cleave the fusion protein and lead to release of a low amount of PR, which in turn acts in trans to generate further PR.
Yields of protease and fl-gal were found to be significantly higher when the gene for PR107 was fused to the 5' end of the E. coli lacZ gene (PR107-fl-gal), and comparison of the level of expression of unfused and flgal-fused mature forms (PR100 and PRl00-fl-gal) suggested that the enhancing effect was post-transcriptional and due to the additional 5' sequence of the PR107 gene. In contrast to a previous report which showed an inactive form of fl-gal-fused protease accumulating in inclusion bodies in E. coli (Giam & Boros, 1988) , all our cloned proteases (except G33 and G33-fl-gal protease mutants) were recovered in an active form under mild, physiological conditions, and none of them, not even the inclusion-forming PR107-fl-gal, required a solubilization step in urea-containing denaturing buffer. Our data are therefore reminiscent of previous observation on high protease yields obtained with certain clones of protease precursors encoding N-terminal sequences of 11 or 56 residues upstream of Pro (1) (Debouck et al., 1990) . According to our results, an upstream sequence of seven residues is sufficient to enhance the protease production without altering protease activity.
Upstream fusion to l~-gal, as in PR107-p-gal, did not result in any detectable cytotoxicity for E. coli cells (Fig.  6) , and a comparison of PR107-and PR107-fl-galexpressing clones with the inactive mutants G33 and G33-fl-gal suggested that the PR107-or G33-induced c.p.e, resulted from the expression of a foreign gene product in E. coil rather than to the enzymic properties of the protease itself. Only the two upstream fusion constructs PR107-fl-gal and G33-fl-gal gave rise to intraceUuar inclusions. This is in contrast to previous reports in which intracellular precipitates were only observed with mature protease or with protease precursors containing both upstream and downstream sequences expressed in heat-shock response-deficient E. coil (Debouck et al., 1990) . Immunoelectron microscopy of the PR107-fl-gal inclusions revealed that protease remained associated with the inclusion bodies, even after processing (Fig. 7) , a phenomenon which could account for the absence of toxicity observed with our fl-gal-fused protease gene constructs.
Processing at Phe-Pro bonds occurred in vivo with a similar efficiency at the PR107-fl-gal and PR100-fl-gal junctions, at the N terminus of the PR107 precursor and at the N and C termini of the fl-gal-fused protease precursor PR107-fl-gal. The N-terminal site was also correctly processed when placed at the protease Cterminal end. This suggests that each autoprocessing site contains its own information for cleavage, independent of protein context, and supports the hypothesis that protease autoprocessing occurs as a result of intermolecular interactions . However, this does not imply that the N-and C-terminal processing are independent events, since the assay used cannot distinguish independence of these two reactions from a situation in which the C-terminal cleavage is dependent on the N-terminal cleavage, but the latter one occurs at a higher rate (Kra~sslich et al., 1989; Strickler et al., 1989) . Moreover, a recent study using mutated fusion proteins expressed in E. coli indicated that altering one of the protease cleavage sites influences the cleavage at the non-mutated site (Louis et al., 1991) .
Upon substitution of the P-G dipeptide at positions P4' and P5' in the C-terminal site by the two positively charged amino acids R-R, protease release was only slightly delayed. This result was not surprising if one considers (i) the topography of residues P4' and P5', positioned downstream of the F-P scissile bond and outside of the active site cleft, (ii) the tolerance of an arginine residue at the P4' position of the natural site at the p9NCgag-p6LIga~ junction (Debouck et al., 1990) and (iii) the tolerance of an arginine residue at P 1' position in non-viral protein substrates of HIV-1 protease, e.g. troponin C and calmodulin (reviewed in Tomasselli et al., 1991) .
The upstream and downstream boundaries of HIV-1 protease constitute its two cleavage sites, SFNF*PQIT at its N terminus and TLNF*PISP at its C terminus, respectively. In the present study, we have focused on the subsite PY of the N-terminal autoprocessing site of the protease for the two following reasons. (i) It has been previously shown that cleavage at the F-P bond constituting the N terminus of the mature protease takes place significantly faster than cleavage at its C-terminal F-P bond , and that the natural Nterminal autoprocessing site VSFNF*PQITL had the highest Vmax/Km ratio (Kra/isslich et al., 1989) . (ii) As a result of mutational analyses of native substrates of HIV-1 protease (Partin et al., 1990; Tomasselli et al., 1991; Tritch et al., 1991) and of its autoprocessing sites Loeb et al., 1989; Louis et al., 1991) , and from theoretical considerations on the structure of the protease (Hellen et al., 1989; Swanstrom et al., 1989) , the following consensus sequence for an autoprocessing site has been proposed: P4 (small and hydrophobic), P3 (undefined), P2 (small), P1 (aromatic or large and hydrophobic), P 1' (proline), P2' (small and hydrophobic), PY (variable).
Amino acid residues at subsites P3 and PY have been postulated to be critical for the precise alignment of a peptide substrate within the protease active site cleft (Sali et al., 1989; Miller et al., 1990) . In addition, once such a ligand is positioned within the cleft, P3 and P3' are adjacent to both flaps of the protease dimer (Erickson et al., 1990; Harte et al., 1990; Lapatto et al., 1989; Miller et al., 1989a, b; Moore et al., 1989; Navia et al., 1989; Suguna et al., 1987; Weber et al., 1989; Wlodawer et al., 1989) . However, no experimental data are available on the influence of the residue at the PY subsite of the Nterminal site on protease autoprocessing, due to the fact that substitutions at this P3' position would change the protease N-terminal sequence and therefore possibly alter its proteolytic activity. This was the case when aspartic acid at PY in the N-terminal site of the protease was substituted for isoleucine: no self-processing was observed with the mutant, whereas cleavage could be rescued in trans by the wild-type protease (Partin et al., 1990) .
For an indirect analysis of the effect of PY substitutions in the upstream site on protease autoprocessing, we introduced a consensus N-terminal processing site at the C-terminal extremity of the protease (at its junction with fl-gal), and substituted a suppressible amber mutant codon for the isoleucine codon at position PY (TLNF*PQambT).
When the amber mutation was assayed for rescue by a series of 12 suppressor tRNAs, only G, H and P substituting for I were found to reduce the processing efficiency (Table 2 ). This suggested a tolerance for a wide variety of amino acid residues at P3' of the N-terminal processing site of HIV-1 protease, except for amino acid substitutions with strong effects on the polypeptide chain secondary structure, e.g. glycine or proline. This implied a relatively high degree of flexibility of the protease flaps in their contact with the amino acid residue at P3'. The design of more efficient HIV protease inhibitors should take into account all available data on protease cleavage of viral and non-viral natural substrates (Rivi6re et aL, 1991) , but the primary and therefore essential event is indeed its own cleavage and release by an autoprocessing mechanism.
